Chemring Group PLC Appointment of Chief Financial Officer (4140A)
May 24 2023 - 1:00AM
UK Regulatory
TIDMCHG
RNS Number : 4140A
Chemring Group PLC
24 May 2023
FOR IMMEDIATE RELEASE 24 MAY 2023
CHEMRING GROUP PLC ("Chemring", the "Group" or the
"Company")
APPOINTMENT OF CHIEF FINANCIAL OFFICER
Chemring is pleased to announce the appointment of James
Mortensen as Chief Financial Officer.
James has a proven track record in industrial, engineering and
technology sectors with extensive experience in building and
managing global, multi-disciplinary finance teams. He joins
Chemring from Smiths Group plc ("Smiths"), the FTSE 100 engineering
group where he has spent the last seven years.
James joined the Smiths M&A team in 2016 and, having played
a key role in scaling ventilator manufacturing during COVID for the
UK Government, he became Chief Financial Officer of the $1.1bn
revenue Smiths Medical Division in 2020. He held this role until
the sale of Smiths Medical for $2.7bn in February 2022, having also
prepared the business for a London listing. He is currently Group
Head of Corporate Development with responsibility for sourcing,
evaluating and executing acquisitions across the four major global
markets where Smiths operate: Security & Defence, Aerospace,
General Industry and Energy.
Prior to Smiths James spent eight years at Smith & Nephew
plc, the FTSE 100 medical technology company where he held
progressively senior finance roles in the areas of group reporting,
strategic planning and corporate finance.
Having graduated from Bristol University James started his
career at KPMG in their audit practice and is a fellow of the
Institute of Chartered Accountants of England and Wales.
James will take over from Andrew Lewis, who announced his
intention to retire on 23 January 2023 and whose notice period runs
until 22 January 2024. The Group is working with James to agree the
date on which he will join Chemring. A further announcement will be
made in due course.
Carl-Peter Forster, Chairman of Chemring, said:
"I am delighted to welcome James to Chemring. He has a proven
track record of success with strong financial and analytical
skills, coupled with valuable M&A experience.
"Considerable work has been done in recent years to strengthen
Chemring's balance sheet and reposition itself. James's broad
experience within the industrials sector will be of great benefit
to the Group as we balance near term performance with long term
growth and value creation for all our stakeholders. The Board look
forward to working with him."
There are no other matters requiring disclosure under Listing
Rule 9.6.13.
-ENDS-
For further information:
Rupert Pittman Group Director of Corporate Affairs, 01794
463401
Chemring Group PLC
James McFarlane MHP Communications 020 3128 8100
Ollie Hoare
Notes to editors
-- Chemring is a FTSE-250 global business that specialises in
the manufacture of high technology products and the provision of
services to the aerospace, defence and security markets
-- Employing approximately 2,500 people worldwide, and with
production facilities in four countries, Chemring meets the needs
of customers in more than fifty countries
-- Chemring is organised under two strategic product segments:
Sensors & Information and Countermeasures & Energetics
-- Chemring has a diverse portfolio of products that deliver
high reliability solutions to protect people, platforms, missions
and information against constantly changing threats
-- Operating in niche markets and with strong investment in
research and development ("R&D"), Chemring has the agility to
rapidly react to urgent customer needs
www.chemring.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOABRGDURGDDGXX
(END) Dow Jones Newswires
May 24, 2023 02:00 ET (06:00 GMT)
Chemring (LSE:CHG)
Historical Stock Chart
From Apr 2024 to May 2024
Chemring (LSE:CHG)
Historical Stock Chart
From May 2023 to May 2024